| Execution period | Valid up to March 30, 2031 |
|---|
NSE filing, NSE: AGIIL. Summary written from the filing by ALFA Finder's alert engine.
AGI Infra Ltd: key numbers
- Share price
- ₹239.90
- Market cap
- ₹2,931 Cr
- Revenue (annual)
- ₹352.5 Cr
- Net profit (annual)
- ₹94.86 Cr
- P/E (TTM)
- 28.6×Sector 34.4×
- Promoter holding
- 71.29%+0.00% QoQ
- FII holding
- 0.92%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from AGI Infra Ltd
All →AGI Infra Board Meeting Date
AGI Infra will hold a board meeting on 6 November 2026 to approve unaudited standalone and consolidated results for Q2 and half-year. The trading window stays closed until 48 hours after the results are declared.
AGI Infra Other Announcement
The company has filed its quarterly shareholding pattern for the quarter ending September 30, 2026, in compliance with SEBI regulatory requirements.
AGI Infra Fund Raise
AGI Infra Limited issued a Postal Ballot notice to shareholders for fund raising. The company proposes a Qualified Institutions Placement (QIP) of equity shares.
AGI Infra Annual General Meeting
AGI Infra Limited is seeking shareholder approval via postal ballot to raise up to Rs. 275 Crore. The funds will be raised through Qualified Institutions Placements (QIP).
- Value
- ₹275.0 Cr
AGI Infra Annual General Meeting
AGI Infra Limited conducted its 21st Annual General Meeting on September 30, 2026. Shareholders transacted ordinary and special business as per the meeting notice.
AGI Infra Fund Raise of ₹275 Cr
AGI Infra Limited approved a Qualified Institutions Placement (QIP) to raise up to Rs. 275 Crore, subject to shareholder approval.
- Value
- ₹275.0 Cr
Other regulatory approval announcements
All →360 One Wam Regulatory Approval
360 ONE Distribution Services' IFSC branch, a subsidiary of 360 ONE WAM, received an IFSCA Certificate of Registration to act as broker dealer, clearing member, depository participant, research entity and distributor. This is a regulatory licence authorising new activities in the IFSC.
Nesco Regulatory Approval
Nesco Limited received a Commencement Certificate from BMC for Tower-2 and Hall-1 at Nesco Center, Goregaon. The company can now proceed with construction and development of the proposed projects, valid until 29 October 2027.
Grasim Industries Regulatory Approval
CCI approved subsidiary ABReN's acquisition of 100% of Solenergi Power from Shell Overseas. The approval clears a regulatory condition for the deal announced on 13 July 2026.
Vedavaag Systems Regulatory Approval
Vedavaag's WOS received IRDAI Certificate of Registration to act as Direct Life & General Insurance Broker. The group enters regulated insurance broking activity.
Hikal Regulatory Approval
Hikal's Bengaluru API facility received a Swissmedic GMP Certificate of Compliance. The certification supports wider access to European and other regulated markets.
Sun Pharmaceutical Industries Regulatory Approval
Sun Pharma gained US FDA approval for ILUMYA in adults with active psoriatic arthritis. The approval extends the drug's psoriasis use, with no financial value stated.